New York Oncology Hematology - Albany Medical Center — Albany, New York

New York Oncology Hematology - Albany Medical Center is a clinical research site located in Albany, New York, United States 12208.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

New York Oncology Hematology - Albany Medical Center has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: ALK+ Advanced NSCLC, Urothelial Carcinoma, Urothelial Carcinoma Bladder.

Sponsors: Takeda, Mirati Therapeutics Inc., Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Hematology - Albany Medical Center?

New York Oncology Hematology - Albany Medical Center has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Hematology - Albany Medical Center conducted?

New York Oncology Hematology - Albany Medical Center has 4 clinical trials on record, with 2 currently active. Their work covers ALK+ Advanced NSCLC, Urothelial Carcinoma, Urothelial Carcinoma Bladder.

Is New York Oncology Hematology - Albany Medical Center accredited by Crixeo Health?

New York Oncology Hematology - Albany Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Oncology Hematology - Albany Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.